Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 281
Selected: 0
NCT IDTitle
NCT02038569An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects
NCT02126371LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects
NCT00135863MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis
NCT01850849Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream
NCT05486117Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema
NCT01555463Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
NCT02695940Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis
NCT03395132Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema
NCT00967148Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer
NCT00722189Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses
NCT02424305Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions
NCT01559883Study on Thrombosis Therapy in German Cancer Patients
NCT01580488A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris
NCT01820260Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis
NCT05098821Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
NCT03549416BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
NCT01293383A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects
NCT01423656Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102
NCT01982552An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life
NCT02650505A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel
NCT04765332Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients
NCT05470114A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD
NCT03958955Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.
NCT00252408Danish Osteoporosis Prevention Study
NCT01922050A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
NCT00051532Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
NCT00408330A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face
NCT03556592Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
NCT07013201A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
NCT01052467Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)
NCT00031096Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne
NCT01787383A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities
NCT04306315Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight
NCT03080545Enstilar in Combination With Biologic Agents
NCT00670241Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris
NCT02411851Treatment of Actinic Keratoses (AK) on the Face
NCT00845481A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris
NCT05099133A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects
NCT04922021An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.
NCT00758862The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo
NCT02392130A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin
NCT03478280Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis
NCT02100813Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis
NCT02753218A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects
NCT07603193Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream
NCT02355639A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin
NCT00958516Assessment of the Phototoxic Potential of LEO 29102 Cream
NCT00216840Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis
NCT02377999Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts
NCT01803022Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer